advertisement
11.4 Prostaglandins (37)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins8659 Comparative analysis of the effects of dorzolamide and latanoprost on ocular hemodynamics in normal tension glaucoma patients
Harris A; Migliardi R; Rechtman E; Cole CN; Yee AB; Garzozi HJ
European Journal of Ophthalmology 2003; 13: 24-31
8834 The effects of latanoprost and brimonidine on blood flow velocity of the retrobulbar vessels: a 3-month clinical trial
Übeyt Inan Ü; Samet Ermis S; Yücel A; Öztürk F
Acta Ophthalmologica Scandinavica 2003; 81: 155-160
8487 Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension
Day DG; Schacknow PN; Wand M; Sharpe ED; Stewart JA; Leech JN; Stewart WC
American Journal of Ophthalmology 2003; 135: 138-143
8712 The efficacy and safety of the timolol/dorzolamide fixed combination versus latanoprost in exfoliation glaucoma
Konstas AGP; Kozobolis VP; Tersis I; Leech JN; Stewart WC
Eye 2003; 17: 41-46
8581 Absence of vasoactive properties of Travoprost in isolated porcine ciliary arteries
Allemann R; Flammer J; Haefliger IO
Klinische Monatsblätter für Augenheilkunde 2003; 152-155
8582 Vasoactive properties of bimatoprost in isolated porcine ciliary arteries
Allemann R; Flammer J; Haefliger IO
Klinische Monatsblätter für Augenheilkunde 2003; 161-164
8633 Conjunctival hyperemia and the use of topical prostaglandins in glaucoma and ocular hypertension
Feldman RM
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 23-35
8495 Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost
Gandolfi SA; Cimino L
Ophthalmology 2003; 110: 609-614
8660 Hypotensive effect of timolol and latanoprost instillation in normal-tension glaucoma
Hashimoto T; Hara T; Takahashi Y; Kubota S; Kubota M; Tsuru T
Japanese Journal of Clinical Ophthalmology 2003; 57: 288-291
8682 Cystoid macular edema associated with latanoprost therapy in a pseudophakic vitrectomized patient after removal of silicone oil endotamponade
Jager M; Jonas JB
European Journal of Ophthalmology 2003; 13: 221-222
8503 Effect of topical latanoprost in eyes after trabeculotomy
Kaneko S; Terauchi H; Nagata M
Japanese Journal of Clinical Ophthalmology 2002; 56: 1545-1548
8692 Ocular hypotensive effects of cholinergic and adrenergic drugs may be influenced by prostaglandins E2 in the human and rabbit eye
Kaplan Messas A; Naveh N; Avni I; Marshall J
European Journal of Ophthalmology 2003; 13: 18-23
8695 Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost
Kashiwagi K; Tsukahara S
British Journal of Ophthalmology 2003; 87: 297-301
8718 The effect of latanoprost on accommodation in young patients with ocular hypertension
Kurtz S; Leibovitch I; Shemesh G; Rothkoff L; Loewenstein A
Journal of Glaucoma 2003; 12: 54-56
8748 Neuroprotective properties of a synthetic docosanoid, unoprostone isopropyl: clinical benefits in the treatment of glaucoma
Melamed S
Drugs Under Experimental and Clinical Research 2002; 28: 63-73
8761 A standardized approach for iris color determination
Niggemann B; Weinbauer G; Vogel F; Korte R
International Journal of Toxicology 2003; 22: 49-51
8491 A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma
Noecker RS; Dirks MS; Choplin NT; Bernstein P; Batoosingh AL; Whitcup SM; The Bimatoprost/Latanoprost Study Group
American Journal of Ophthalmology 2003; 135: 55-63
8774 The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension
Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P
Archives of Ophthalmology 2003; 121: 453-457
8862 A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator multicenter study
Parrish RK 2nd; Palmberg P; Wang-Pui Sheu MA; XLT STUDY GROUP
American Journal of Ophthalmology 2003; 135: 688-703
8492 Fine structural evaluation of the iris after unilateral treatment with latanoprost in patients undergoing bilateral trabeculectomy (the Mainz II study)
Pfeiffer N; Grierson I; Goldsmith H; Appleton P; Hochgesand D; Winkgen A
Archives of Ophthalmology 2003; 121: 23-31
8494 Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues
Sharif NA; Kelly CR; Crider JY
Investigative Ophthalmology and Visual Science 2003; 44: 715-721
8505 Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor
Sharif NA; Kelly CR; Crider JY
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 313-324
8498 Bimatoprost (Lumigan®) is an agonist at the cloned human ocular FP prostaglandin receptor: real-time FLIPR-based intracellular Ca2+ mobilization studies
Sharif NA; Kelly CR; Williams GW
Prostaglandins Leukotrienes and Essential Fatty Acids 2003; 68: 27-33
8501 Additive hypotensive effect of latanoprost and unoprostone for primary open angle glaucoma
Soma T; Kiuchi Y; Fukui K; Hayashida Y; Ohnishi T; Ishimoto I; Saito Y
Japanese Journal of Clinical Ophthalmology 2002; 56: 1811-1815
8496 Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost
Stewart WC; Kolker AE; Stewart JA; Leech JN; Jackson AL
American Journal of Ophthalmology 2003; 135: 314-320
